Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

03 Jan 2024 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed media release titled ‘Glenmark is the first to launch Biosimilar of Popular Anti?Diabetic Drug, Liraglutide, in India’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..